Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

MBK Partners to acquire Skinidea and Life&bio

PRIVATESep 03, 20264 days ago

Acquiring Company

MBK Partners

Acquired Company

Skinidea

Jongno-guSouth KoreaFinancial ServicesVenture CapitalAngel InvestmentHealth CareE CommerceFashionBeautyCosmetics

Description

MBK Partners is set to acquire Skinidea and Life&bio for approximately 300 billion won. This acquisition gives MBK management control previously held by Morgan Stanley Private Equity. The deal marks MBK's return to management control investments in Korea after two years. The existing management of both companies will remain in place post-transaction.

Company Information

Company

MBK Partners

Location

Jongno-gu, Seoul, South Korea

About

MBK Partners is one of the largest independent private equity firms in North Asia and has a strong track record of leveraged buyouts and acquisitions across various industries.

Don't miss MBK Partners's next move

Get an email the moment MBK Partners makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Seikyu
Likely contact at this company
••••••••@••••••••

See Seikyu's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for MBK Partners's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Skinidea?

Skinidea was acquired by MBK Partners, based in Jongno-gu. The deal was reported on September 3, 2026. MBK Partners is one of the largest independent private equity firms in North Asia and has a strong track record of leveraged buyouts and acquisitions across various industries. MBK Partners is privately held and operates in Financial Services.

When did MBK Partners acquire Skinidea?

MBK Partners's acquisition of Skinidea was reported on September 3, 2026. MBK Partners is set to acquire Skinidea and Life&bio for approximately 300 billion won. This acquisition gives MBK management control previously held by Morgan Stanley Private Equity. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Skinidea do?

Skinidea is a beauty brand operator known for its innovative skincare products. The company operates brands such as 'Medipeel' and 'Derma Maison.' It was previously majority-owned by Morgan Stanley Private Equity. It is privately held, operating in Health Care, and is based in South Korea.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.